This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Determining the right percentage of income to save for retirement is crucial for millennials. Find out the ideal savings rate for a secure future.
24,766 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A prominent institutional investor revealed a sizable Callaway Golf stake as the stock surged. This article breaks do...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
When Broadcom's guidance disappointed, a sudden market pullback opened a legitimate AI buying opportunity. This artic...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Cerebras exploded higher on its debut, but what comes next for investors? This guide breaks down the hype, the fundam...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
Space-focused investors have watched Redwire stock keep dropping as headlines swirl about contracts, funding, and exe...
Crypto builders concede the infrastructure is there, but mass adoption remains elusive. This article digs into why bl...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
After a strong rally, investors ask if AMD remains a smart bet. This in-depth look weighs AI roadmaps, growth drivers...